Accelerate Diagnostics, Inc.
Accelerate Diagnostics is dedicated to revolutionizing microbiology laboratories with innovative rapid diagnostic systems. Their mission is to help clinicians combat antibiotic resistance and improve patient care through faster and more accurate pathogen identification and antimicrobial susceptibility testing.
Industries
Nr. of Employees
medium (51-250)
Accelerate Diagnostics, Inc.
3101 N. Campbell Ave, Tucson, AZ 85719
Patents
Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing
US-11940757-B2
View DetailsInstrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US-11085064-B2
View DetailsLens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing
US-11079719-B2
View DetailsInstrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US-10669566-B2
View Details
Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing
US-11940757-B2
View DetailsInstrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US-11085064-B2
View DetailsLens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing
US-11079719-B2
View DetailsInstrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US-10669566-B2
View DetailsProducts
Phenotypic AST kit for direct testing of positive blood cultures (AST and ID/AST configurations)
A consumable kit intended for direct phenotypic antimicrobial susceptibility testing from positive blood culture samples; available in AST-only and combined ID/AST configurations and designed for use with automated testing platforms.
Automated sample-preparation platform for direct mass-spectrometry identification
An automated instrument workflow that prepares positive blood culture samples for direct identification by mass-spectrometry methods by removing interfering material and presenting clean analyte for ID.
Holographic imaging–based rapid AST system
A rapid AST platform that uses holographic or advanced optical imaging to assess bacterial growth/response and report susceptibility results and confirmatory resistance phenotypes (e.g., ESBL) in markedly reduced timeframes.
Phenotypic AST kit for direct testing of positive blood cultures (AST and ID/AST configurations)
A consumable kit intended for direct phenotypic antimicrobial susceptibility testing from positive blood culture samples; available in AST-only and combined ID/AST configurations and designed for use with automated testing platforms.
Automated sample-preparation platform for direct mass-spectrometry identification
An automated instrument workflow that prepares positive blood culture samples for direct identification by mass-spectrometry methods by removing interfering material and presenting clean analyte for ID.
Holographic imaging–based rapid AST system
A rapid AST platform that uses holographic or advanced optical imaging to assess bacterial growth/response and report susceptibility results and confirmatory resistance phenotypes (e.g., ESBL) in markedly reduced timeframes.
Services
Support for clinical adoption of rapid AST and direct-from-blood-culture workflows including dissemination of outcomes data, case studies, and presentations to clinical and laboratory teams.
Provision of technical presentations, posters, and videos summarizing analytical and clinical performance for laboratorians and clinicians at scientific meetings.
Support for clinical adoption of rapid AST and direct-from-blood-culture workflows including dissemination of outcomes data, case studies, and presentations to clinical and laboratory teams.
Provision of technical presentations, posters, and videos summarizing analytical and clinical performance for laboratorians and clinicians at scientific meetings.
Expertise Areas
- Rapid phenotypic antimicrobial susceptibility testing
- Bloodstream infection diagnostics and workflow optimization
- Laboratory automation and sample-preparation workflows
- Clinical validation and multi-site performance studies
Key Technologies
- Phenotypic antimicrobial susceptibility testing (AST)
- Holographic imaging for microbial growth/phenotype detection
- MALDI-TOF mass-spectrometry identification (direct-from-blood-culture prep)
- Multi-channel disposable test cassettes / microfluidic consumables
News & Updates
Submission of the Accelerate WAVE™ system and positive blood culture gram-negative test kit to the FDA for regulatory approval.
Accelerate Diagnostics announced that the FDA has granted 510(k) clearance for the Accelerate Arc™ system, an automated platform for rapid microbial identification directly from positive blood culture samples.
The WAVE system demonstrated rapid antimicrobial susceptibility testing directly from positive blood culture bottles, delivering results within 4.5 hours.
Research highlighting the speed and accuracy of the Accelerate Pheno system for Gram-negative bacteria.
Study demonstrating the system's ability to confirm ESBL production rapidly.
Research on automated sample prep for rapid pathogen ID.
Submission of the Accelerate WAVE™ system and positive blood culture gram-negative test kit to the FDA for regulatory approval.
Accelerate Diagnostics announced that the FDA has granted 510(k) clearance for the Accelerate Arc™ system, an automated platform for rapid microbial identification directly from positive blood culture samples.
The WAVE system demonstrated rapid antimicrobial susceptibility testing directly from positive blood culture bottles, delivering results within 4.5 hours.
Research highlighting the speed and accuracy of the Accelerate Pheno system for Gram-negative bacteria.
Study demonstrating the system's ability to confirm ESBL production rapidly.
Research on automated sample prep for rapid pathogen ID.